Our services to support you at every stage.
Detect cardiovascular risk earlier with advanced vascular analysis
This module enables an instant (spot) measurement of advanced cardiovascular parameters, notably those related to arterial stiffness.
- Visualisation of values as trends (day/night, time slots, overall)
- Multi-format display: charts, tables and pie charts
- Integrated patient diary (paper or digital mode)
- Automatic analysis of long-term trends
- Risk stratification according to international guidelines
- Creation of an individualised risk profile
- Automatic generation of reports
- Customisable text modules
Displays the pulse wave shape (current or all waves),
enabling visualisation of blood pressure behaviour over time.
Presents the measured values of the current reading
(pressure, heart rate, PWV, AIx…).
History of the patient’s spot measurements,
making it easier to compare and monitor over time.
Time savings in analysis and report writing
Simplified reading of 24-hour data
Clinical decision support through automatic risk stratification
Easier therapeutic follow-up with trend analysis over time
A complete view of cardiovascular risk: blood pressure monitoring and advanced vascular analysis
The (ABPM) module and the “Spot Measurement” module are complementary in cardiovascular assessment.
ABPM makes it possible to analyse changes in blood pressure over 24 hours or more, highlighting day/night variations and the effectiveness of a treatment.
In parallel, the “Spot Measurement” module provides a much finer and more qualitative level of analysis by assessing the state of the vascular system at a given moment.
This complementarity therefore provides a view of the patient that is both dynamic and physiological, for a more accurate diagnosis and optimised care.
Get support from our experts at every stage of your project.
Our expert advice
“Do not limit yourself to the blood pressure value: systematically analyse PWV and central pressure, as these are what reveal vascular changes and the patient’s true cardiovascular risk at the earliest stage.”
Régis Andrieu
Cardiology Director